{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:50:49Z","timestamp":1792633849556,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jconrel.2022.11.054","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T16:53:53Z","timestamp":1671123233000},"page":"727-737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["A Biomimetic Metal-Organic Framework Nanosystem Modulates Immunosuppressive Tumor Microenvironment Metabolism to Amplify Immunotherapy"],"prefix":"10.1016","volume":"353","author":[{"given":"Huaiji","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jconrel.2022.11.054_bb0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41577-019-0269-6","article-title":"Enhancing cancer immunotherapy with nanomedicine","volume":"20","author":"Irvine","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2022.11.054_bb0010","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3389\/fimmu.2020.01508","article-title":"Clinical and recent patents applications of PD-1\/PD-L1 targeting immunotherapy in cancer treatment-current progress, strategy, and future perspective","volume":"11","author":"Guo","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2022.11.054_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2022.04.041","article-title":"Combination of oxaliplatin and POM-1 by nanoliposomes to reprogram the tumor immune microenvironment","volume":"347","author":"Fu","year":"2022","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.jconrel.2022.11.054_bb0020","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1158\/2326-6066.CIR-19-0228","article-title":"Trifluridine\/Tipiracil plus Oxaliplatin improves PD-1 blockade in colorectal cancer by inducing immunogenic cell death and depleting macrophages","volume":"7","author":"Limagne","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"18","key":"10.1016\/j.jconrel.2022.11.054_bb0025","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.7150\/thno.45391","article-title":"Nanomicelle protects the immune activation effects of paclitaxel and sensitizes tumors to anti-PD-1 immunotherapy","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.jconrel.2022.11.054_bb0030","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1021\/acsnano.9b07212","article-title":"Smart Nanovesicle-mediated immunogenic cell death through tumor microenvironment modulation for effective photodynamic immunotherapy","volume":"14","author":"Yang","year":"2020","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.jconrel.2022.11.054_bb0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00018-020-03581-0","article-title":"Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance","volume":"78","author":"Wei","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jconrel.2022.11.054_bb0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semcancer.2017.03.001","article-title":"Cancer acidity: an ultimate frontier of tumor immune escape and a novel target of immunomodulation","volume":"43","author":"Huber","year":"2017","journal-title":"Semin. Cancer Biol."},{"issue":"9","key":"10.1016\/j.jconrel.2022.11.054_bb0045","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41568-020-0273-y","article-title":"Metabolism of immune cells in cancer","volume":"20","author":"Leone","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.jconrel.2022.11.054_bb0050","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41577-019-0140-9","article-title":"Metabolic interventions in the immune response to cancer","volume":"19","author":"O\u2019Sullivan","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2022.11.054_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202005236","article-title":"Nanotechnology for hepatocellular carcinoma: from surveillance, diagnosis to management","volume":"17","author":"Wu","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2022.11.054_bb0060","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2014.12.030","article-title":"Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications","volume":"200","author":"Wicki","year":"2015","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.jconrel.2022.11.054_bb0065","doi-asserted-by":"crossref","first-page":"11017","DOI":"10.1021\/acsnano.9b07789","article-title":"Tumor-targeted Cascade Nanoreactor based on metal-organic frameworks for synergistic Ferroptosis-starvation anticancer therapy","volume":"14","author":"Wan","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.11.054_bb0070","first-page":"342","article-title":"Nanostructured metal-organic frameworks and their bio-related applications, Coordin","volume":"307","author":"Gimenez-Marques","year":"2016","journal-title":"Chem. Rev."},{"issue":"37","key":"10.1016\/j.jconrel.2022.11.054_bb0075","article-title":"Nanoparticles of metal-organic frameworks: on the road to in vivo efficacy in biomedicine","volume":"30","author":"Simon-Yarza","year":"2018","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2022.11.054_bb0080","doi-asserted-by":"crossref","first-page":"1804105","DOI":"10.1002\/smll.201804105","article-title":"Recent advances in cell membrane-camouflaged nanoparticles for cancer phototherapy","volume":"15","author":"Zhen","year":"2019","journal-title":"Small"},{"issue":"12","key":"10.1016\/j.jconrel.2022.11.054_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202006484","article-title":"Immune cell membrane-coated biomimetic nanoparticles for targeted Cancer therapy","volume":"17","author":"Oroojalian","year":"2021","journal-title":"Small"},{"issue":"16","key":"10.1016\/j.jconrel.2022.11.054_bb0090","doi-asserted-by":"crossref","first-page":"1606209","DOI":"10.1002\/adma.201606209","article-title":"Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization","volume":"29","author":"Dehaini","year":"2017","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.jconrel.2022.11.054_bb0095","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1021\/acs.nanolett.1c00168","article-title":"Platelet-membrane-coated nanoparticles enable vascular disrupting agent combining anti-Angiogenic drug for improved tumor vessel impairment","volume":"21","author":"Li","year":"2021","journal-title":"Nano Lett."},{"issue":"43","key":"10.1016\/j.jconrel.2022.11.054_bb0100","doi-asserted-by":"crossref","first-page":"9581","DOI":"10.1002\/adma.201602173","article-title":"Cancer-cell-biomimetic nanoparticles for targeted therapy of homotypic tumors","volume":"28","author":"Sun","year":"2016","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.jconrel.2022.11.054_bb0105","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1021\/acs.nanolett.0c01654","article-title":"Multimodal enzyme delivery and therapy enabled by cell membrane-coated metal-organic framework nanoparticles","volume":"20","author":"Zhuang","year":"2020","journal-title":"Nano Lett."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922008082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922008082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:40:31Z","timestamp":1759164031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922008082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":21,"alternative-id":["S0168365922008082"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.054","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Biomimetic Metal-Organic Framework Nanosystem Modulates Immunosuppressive Tumor Microenvironment Metabolism to Amplify Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}